The in vitro and in vivo effects of mefloquine on Trypanosoma brucei brucei.
Blood stream forms of Trypanosoma brucei brucei were grown over mouse kidney (MK) cells in minimum essential medium with various concentrations of mefloquine. The drug was observed to inhibit multiplication of the parasites in vitro. Groups of male albino mice were treated with mefloquine at 24, 48 and hours after T. b. brucei infection. Mefloquine at 0.03 mg/kg body weight administered for 4 consecutive days cleared the infection. No trypanosomes were detected in the blood of these mice for 90 days and over after the clearance of parasite from the blood. The doses for both the in vitro and in vivo therapy, were well below those prescribed for humans.
Otigbuo
I N
IN
Department of Medical Microbiology & Parasitology, College of Medicine, University of Lagos, Nigeria.
Onabanjo
A O
AO
D000818:Animals; D002478:Cells, Cultured; D004195:Disease Models, Animal; D004334:Drug Administration Schedule; D007668:Kidney / Q000469:parasitology; D008297:Male; D015767:Mefloquine / Q000627:therapeutic use*; D051379:Mice; D014346:Trypanosoma brucei brucei; D014353:Trypanosomiasis, African / Q000188:drug therapy*
D015767:Mefloquine